BCT and BCTXL Related Headlines

Go Back

Mar 5, 2026 04:04PM BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Jan 27, 2026 07:30AM BriaCell reports extended survival in metastatic breast cancer trial
Jan 27, 2026 07:30AM BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Jan 15, 2026 04:05PM BriaCell completes $30 million public offering of units
Jan 15, 2026 04:05PM BriaCell Therapeutics Announces Closing of US$30 million Public Offering
Jan 13, 2026 09:00PM BriaCell prices $30 million public offering at $5.59 per unit
Jan 13, 2026 09:00PM BriaCell Therapeutics Announces Pricing of $30 million Public Offering

BCT and BCTXL Related Press Releases

Go Back

Mar 5, 2026 04:04PM BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Jan 27, 2026 07:30AM BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Jan 15, 2026 04:05PM BriaCell Therapeutics Announces Closing of US$30 million Public Offering
Jan 13, 2026 09:00PM BriaCell Therapeutics Announces Pricing of $30 million Public Offering

BCT and BCTXL Related SEC Filings

Go Back